Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania.
Fertil Steril. 2019 Sep;112(3):586-593. doi: 10.1016/j.fertnstert.2019.04.024. Epub 2019 Jun 11.
To determine the association between serum androgens measured by high-resolution liquid chromatography-mass spectrometry and coronary artery calcium (CAC) scores.
Cross-sectional study.
Academic institution.
PATIENT(S): A total of 239 women, aged 40-75 years, with CAC testing and complete cardiovascular disease risk evaluation. Total T, DHEA, and androstenedione were measured using high-resolution liquid chromatography-mass spectrometry, whereas E and sex hormone-binding globulin were measured using commercial assays.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Independent associations between CAC scores and sex steroids.
RESULT(S): Overall, 164 subjects had a CAC score < 10, 48 had a CAC score between 10 and 100, and 27 had a score > 100. There were no differences in sex hormone levels between women with CAC scores > 10 vs. CAC scores ≤ 10. In multivariable models adjusting for age, body mass index, and low-density lipoprotein cholesterol, a higher T/E ratio was associated with an elevated CAC score, with an unadjusted odds ratio associated with 1-SD change in log-transformed T/E of 1.38 (95% confidence interval 1.01-1.89) and adjusted OR 1.02 (95% confidence interval 1.002-1.04). Total T, DHEA, androstenedione, sex hormone-binding globulin, and E levels were not associated with increased CAC.
CONCLUSION(S): In the general population, there are mixed reports regarding the relationship between serum androgens and risk factors for cardiovascular disease, and limited information on the relationship between androgens and subclinical atherosclerosis. Our study shows that increased androgens relative to estrogens may have a weak but independent association with subclinical atherosclerosis, as measured by CAC scores.
通过高分辨率液相色谱-质谱法测定血清雄激素与冠状动脉钙(CAC)评分之间的关系。
横断面研究。
学术机构。
共有 239 名年龄在 40-75 岁之间的女性进行了 CAC 检测和完整的心血管疾病风险评估。采用高分辨率液相色谱-质谱法测定总 T、DHEA 和雄烯二酮,采用商业检测法测定 E 和性激素结合球蛋白。
无。
CAC 评分与性激素之间的独立相关性。
总体而言,164 例患者 CAC 评分<10,48 例患者 CAC 评分在 10-100 之间,27 例患者 CAC 评分>100。CAC 评分>10 与 CAC 评分≤10 的女性之间的性激素水平无差异。在调整年龄、体重指数和低密度脂蛋白胆固醇的多变量模型中,较高的 T/E 比值与 CAC 评分升高相关,未经调整的优势比与 log 转换 T/E 的 1-SD 变化相关为 1.38(95%置信区间 1.01-1.89),调整后的 OR 为 1.02(95%置信区间 1.002-1.04)。总 T、DHEA、雄烯二酮、性激素结合球蛋白和 E 水平与 CAC 增加无关。
在一般人群中,关于血清雄激素与心血管疾病危险因素之间的关系存在混合报告,关于雄激素与亚临床动脉粥样硬化之间的关系的信息有限。我们的研究表明,与雌激素相比,雄激素的增加可能与 CAC 评分测量的亚临床动脉粥样硬化有微弱但独立的关联。